references
121. Nakamura H., Takasawa M., Kashara S., Tsuda A., Momotsu T., Ito S., Shibata A. Effects of Acute Protein Loads of Different Sources on Renal Function of Patients with Diabetic Nephropathy. Tohoku J. Exp. Med. 1989; 159:153 – 162. [ Pubmed ] 122. Kitazato H., Fujita H., Shimotomai T., Kagaya E., Narita T., Kakei M., Ito S. Effects of Chronic Intake of Vegetable Protein Added to Animal or Fish Protein on Renal Hemodynamics. Nephron. 2002; 90:31 – 36. [ Pubmed ] 123. Chan A. Y., Cheng M. L., Keil L. C., Myers B. D. Functional Response of Healthy and Diseased Glomeruli to A Large, Protein-Rich Meal. J. Clin. Invest. 1988; 81:245 – 254. [ PMC Free Article ] [ Pubmed ] 124. D’ Amico G., Gentile M. G. Influence of Diet on Lipid Abnormalities in Human Renal Disease. Am. J. Kidney Dis. 1993; 22:151 – 157. [ Pubmed ] 125. Barsotti G., Navalesi R., Giampietro O., Ciardella F., Morelli E., Cupisti A., Mantovanelli A., Giovannetti S. Effects of A Vegetarian, Supplemented Diet on Renal Function, Proteinuria, and Glucose Metabolism in Patients with‘ Overt’ Diabetic Nephropathy and Renal Insufficiency. Contrib. Nephrol. 1988; 65:87 – 94. [ Pubmed ]
Prostate Health References
1. Aryal, M., et al. 2007 Dec. Oxidative Stress in Benign Prostate Hyperplasia. Nepal Med Coll J 9( 4): 222 – 24. 2. Baniel, J., et al. 2000 Jul. Sexual Function in 131 Patients with Benign Prostatic Hyperplasia before Prostatectomy. Eur Urol 38( 1): 53 – 58. 3. Barnard, R. J., and W. J. Aronson. 2009 Dec. Benign Prostatic Hyperplasia: Does Lifestyle Play a Role? Phys Sportsmed 37( 4): 141-46. 4. Berger, a. P, et al. 2005a. Vascular Damage Induced by Type 2 Diabetes Mellitus as a Risk Factor for Benign Prostatic Hyperplasia. Diabetologia 48( 4): 784 – 89. 5. Berger, a. P., et al. 2006 Nov. Atherosclerosis As a Risk Factor for Benign Prostatic Hyperplasia. Bju Int 98( 5): 1038 – 42. 6. Bravi, F., et al. 2006 Jan. Food Groups and Risk of Benign Prostatic Hyperplasia. Urology 67( 1): 73 – 79. 7. Crawford, E. D., et al. 2011 Sep. Effects of 100 and 300 Units of Onabotulinum Toxin A On Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: a Phase II Randomized Clinical Trial. J Urol 186( 3): 965 – 70. 8. Dutkrewicz, S. 1996. Usefulness of Cernilton in the Treatment of Benign Prostatic Hyperplasia. Int Urol Nephr 28( 1): 49 – 53. 9. Fibbi, B., et al. 2010. Jun 1. Chronic Inflammation in the Pathogenesis
70